Cannabis consumer packaged goods company Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) announced on Thursday its second quarter financial results for the three months ended June 30, 2024, revealing net revenues of CA$29.2 million. ($21.3 million). That's an increase of 33% year-over-year and 16% compared to the previous quarter. "After our best start to a year ever, we are thrilled to report our best Q2 in history, with exceptional financial performance setting a new Q2 record in revenue and all-time records in gross margin and adjusted EBITDA," Hugo Alves, CEO of Auxly, said. "We are particularly proud of our significant gains in market share across all three of our core product categories, especially in the vapor segment where we are currently leading the growing all-in-one category, securing an impressive 32% share of market." read more
Auxly is a Canada-based medical cannabis company that produces and sells marijuana products including edibles, capsules, vaporizers and oil extracts for the commercial market.